Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-02
DOI
10.3389/fonc.2021.609054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Noninvasive CT radiomic model for preoperative prediction of lymph node metastasis in early cervical carcinoma
- (2020) Jiaming Chen et al. BRITISH JOURNAL OF RADIOLOGY
- A clinical-radiomics nomogram for the preoperative prediction of lymph node metastasis in colorectal cancer
- (2020) Menglei Li et al. Journal of Translational Medicine
- Deep learning in medical image registration: a survey
- (2020) Grant Haskins et al. MACHINE VISION AND APPLICATIONS
- Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer
- (2020) Xueyi Zheng et al. Nature Communications
- Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging
- (2020) Xue Sha et al. BMC MEDICAL IMAGING
- Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features
- (2020) Zongqiong Sun et al. Journal of X-Ray Science and Technology
- Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
- (2019) Zhijie Wang et al. JAMA Oncology
- Frequency and imaging features of abdominal immune-related adverse events in metastatic lung cancer patients treated with PD-1 inhibitor
- (2019) Francesco Alessandrino et al. Abdominal Radiology
- Novel clinical and radiomic predictors of rapid disease progression phenotypes among lung cancer patients treated with immunotherapy: An early report
- (2019) Ilke Tunali et al. LUNG CANCER
- Artificial intelligence in cancer imaging: Clinical challenges and applications
- (2019) Wenya Linda Bi et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Predicting Response to Cancer Immunotherapy using Non-invasive Radiomic Biomarkers
- (2019) S Trebeschi et al. ANNALS OF ONCOLOGY
- VoxelMorph: A Learning Framework for Deformable Medical Image Registration
- (2019) Guha Balakrishnan et al. IEEE TRANSACTIONS ON MEDICAL IMAGING
- Predictors of Early Response to Immunotherapy in Head and Neck Cancer: A Secondary Clinical and Radiomic Analysis of a Prospective Randomized Trial with Nivolumab
- (2019) Y. Yu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Unsupervised 3D End-to-End Medical Image Registration With Volume Tweening Network
- (2019) Shengyu Zhao et al. IEEE Journal of Biomedical and Health Informatics
- Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review
- (2018) Feifei Teng et al. CANCER LETTERS
- Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma
- (2018) Xianzheng Tan et al. EUROPEAN RADIOLOGY
- Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer
- (2018) Chad Tang et al. Scientific Reports
- Growth and Immune Evasion of Lymph Node Metastasis
- (2018) Dennis Jones et al. Frontiers in Oncology
- A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
- (2018) Roger Sun et al. LANCET ONCOLOGY
- Imaging of Cancer Immunotherapy: Current Approaches and Future Directions
- (2018) Mizuki Nishino et al. RADIOLOGY
- Prognostic effects of preoperative obstructive pneumonitis or atelectasis and comparison with tumor size in non-small cell lung cancer
- (2017) Zhaofei Pang et al. Journal of Thoracic Disease
- RECIST 1.1—Update and clarification: From the RECIST committee
- (2016) Lawrence H. Schwartz et al. EUROPEAN JOURNAL OF CANCER
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab
- (2015) S. H. Tirumani et al. Cancer Immunology Research
- The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository
- (2013) Kenneth Clark et al. JOURNAL OF DIGITAL IMAGING
- The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): A Completed Reference Database of Lung Nodules on CT Scans
- (2011) Samuel G. Armato et al. MEDICAL PHYSICS
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started